Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

AIMday Antimicrobial Resistance - registration for academics now open

Events General Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes?

If you answer YES to any of the above, now is the time to register for the AIMday in Antimicrobial Resistance.

The event takes place on Thursday 4 July at the Blavatnik School of Government and is hosted by The University of Oxford, together with the NIHR Community Healthcare MIC.

FREE registration for academics is now open and closes on Thursday 27 June (advance registration is essential).

A range of companies are registered to attend, and it will be a fantastic opportunity for researchers looking to network with industry and discuss relevant questions.

Companies registered to attend

  • Abbott
  • Academic Health Science Network for the North East and North Cumbria
  • Amprologix
  • Astrego Diagnostics
  • Centauri Therapeutics
  • Destiny Pharma
  • Evotec
  • GeneFirst
  • GSK
  • Ingenza
  • Innovate UK
  • metaLinear
  • Oppilotech
  • Oxford Drug Design
  • Pedanius Therapeutics
  • Randox Laboratories
  • Release Life Sciences and Diagnostics
  • Summit Therapeutics
  • Thermo Fisher Scientific

To see the questions posed by these companies, please visit aimday.se/amr-2019/questions-listing.

Register here: http://aimday.se/amr-oxford-2019. 

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

Drug could help diabetic hearts recover after heart attack - Oxford research

Researchers at the University of Oxford have identified a drug that could ultimately help improve heart function in people with diabetes who have heart attacks.

Largest ever global study of tuberculosis identifies genetic causes of drug resistance

Using cutting-edge genomic sequencing techniques, researchers at the University of Oxford have identified almost all the genomic variation that gives people resistance to 13 of the most common tuberculosis (TB) drug treatments.

AIMday in Women's Health - registration for academics now open

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Peter Horby receives prestigious award for outstanding service to public health

The Faculty of Public Health (FPH) has awarded its prestigious Alwyn Smith Prize to Professor Sir Peter Horby (Nuffield Department of Medicine) for 2020/2021 in recognition of his outstanding service to public health as a global leader in epidemic science.

Six new Fellowships announced as part of Oxford-Bristol Myers Squibb Fellowships Programme

The Oxford - Bristol Myers Squibb (BMS) Fellowships Programme continued to demonstrate significant progress over the last year, despite the challenges associated with the global pandemic, including restricted lab access and work from home guidance. Today, we are pleased to announce six new Oxford-BMS Fellowships for 2021.